Continuing Education
Evolving Treatment Paradigms in Bladder Cancer Across the Care Continuum
Best Suited For: Pharmacist, Nurse, Pharmacy Technician, Nurse Practitioner, Physician Assistant
CE Credits: 1 hours
Activity Description
This session will review contemporary treatment approaches for bladder cancer across localized, perioperative, and advanced disease settings. Participants will explore the expanding role of immunotherapy and antibody–drug conjugates, with focused discussion on adjuvant immunotherapy and enfortumab vedotin plus pembrolizumab in modern treatment paradigms. Emphasis will be placed on clinical decision-making, therapy sequencing, and practical considerations for implementation in oncology practice.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Summarize recently approved and emerging bladder-sparing therapies for BCG-unresponsive non–muscle invasive bladder cancer (NMIBC), including systemic and intravesical treatment options.
- Explore emerging data supporting the use of enfortumab vedotin plus pembrolizumab in muscle-invasive bladder cancer (MIBC), including perioperative strategies and implications for cisplatin-eligible and cisplatin-ineligible patients.
- Review current treatment strategies and sequencing considerations in locally advanced and metastatic urothelial carcinoma, including integration of antibody–drug conjugates, targeted therapy, and immunotherapy combinations based on clinical trial data.
- Discuss evolving administration strategies for immune checkpoint inhibitors, including intravenous and subcutaneous formulations of pembrolizumab and nivolumab, and their potential impact on patient care and clinic workflow.
- Recognize key adverse effects and mitigation strategies associated with immune checkpoint inhibitors and antibody-drug conjugates used in bladder cancer treatment.
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, eligible continuing education credit will be submitted to the appropriate accrediting body. Pharmacist and pharmacy technician credit will be reported to ACPE and reflected in your CPE Monitor profile within 24 hours. Reporting timelines for other healthcare professions may vary by accrediting body or state board.
CE information for nurses, nurse practitioners (NPs), and physician assistants (PAs) can be found here.
